CEUAX
Price
$63.13
Change
+$0.32 (+0.51%)
Updated
Sep 29 closing price
Net Assets
135.4B
MSIAX
Price
$24.28
Change
+$0.07 (+0.29%)
Updated
Sep 26 closing price
Net Assets
2.77B
Interact to see
Advertisement

CEUAX vs MSIAX

Header iconCEUAX vs MSIAX Comparison
Open Charts CEUAX vs MSIAXBanner chart's image
American Funds EUPAC 529-A
Price$63.13
Change+$0.32 (+0.51%)
VolumeN/A
Net Assets135.4B
Morgan Stanley Inst Intl Advtg C
Price$24.28
Change+$0.07 (+0.29%)
VolumeN/A
Net Assets2.77B
CEUAX vs MSIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CEUAX vs. MSIAX commentary
Sep 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CEUAX is a Buy and MSIAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CEUAX has more cash in the bank: 135B vs. MSIAX (2.77B). CEUAX pays higher dividends than MSIAX: CEUAX (0.67) vs MSIAX (0.00). CEUAX was incepted earlier than MSIAX: CEUAX (24 years) vs MSIAX (10 years). MSIAX (2.00) is less costly to investors than CEUAX (0.85). CEUAX is a more actively managed with annual turnover of: 35.00 vs. MSIAX (26.00). CEUAX has a lower initial minimum investment than MSIAX: CEUAX (250) vs MSIAX (1000). MSIAX (5.75) and CEUAX (5.57) have marching annual gain over last year. CEUAX return over 5 years is better than : 17.69 vs. MSIAX (10.31).
CEUAXMSIAXCEUAX / MSIAX
Total Expense Ratio0.852.0043%
Annual Report Gross Expense Ratio0.852.0043%
Fund Existence24 years10 years-
Gain YTD18.84612.930146%
Front Load4%N/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets135B2.77B4,867%
Annual Yield % from dividends0.670.00-
Returns for 1 year5.575.7597%
Returns for 3 years52.3453.2898%
Returns for 5 years17.6910.31172%
Returns for 10 years60.2098.9861%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RLMD1.810.15
+9.04%
Relmada Therapeutics
CLDX26.140.89
+3.52%
Celldex Therapeutics
LINE38.250.75
+2.00%
Lineage Inc.
MLP19.030.06
+0.32%
Maui Land & Pineapple Co
RANGU11.00N/A
N/A
Range Capital Acquisition Corp